Resources for Qelbree and ADHD

Explore resources to learn more about navigating life with ADHD—and finding help with Qelbree.

Qelbree and ADHD resources for children

Qelbree Pediatric Brochure

Learn all about Qelbree, how it's taken, safety information, and available support and savings programs, and discover how it can help children 6-17 years old manage their ADHD symptoms.

Healthcare Provider Discussion Guide

What questions do you have for your child’s healthcare provider? Create a personalized conversation guide to use at your next appointment.

Qelbree Progress Tracker

Everyone’s experience with ADHD and Qelbree is different. Use this tool to keep track of your child’s symptoms, dosing schedule, and more.

Tips for success

Once prescribed, help your child get the best results with Qelbree and stay on track with their treatment.

Qelbree and ADHD resources for adults

Qelbree Adult Brochure

Learn how Qelbree can help adults manage ADHD symptoms, and discover some key tips and steps for getting started with treatment.

Healthcare Provider Discussion Guide

What questions do you have for your healthcare provider? Create a personalized conversation guide to use at your next appointment.

Qelbree Progress Tracker

Everyone’s experience with ADHD and Qelbree is different. Use this tool to keep track of your symptoms, dosing schedule, and more.

ADHD Symptom Checklist

If you’re living with ADHD and struggling to manage the impact, this guide can help you better understand your symptoms and get the support you need.

Tips for success

Once prescribed, learn about ways to get the best results with Qelbree and stay on track with your treatment.

ADHD community resources

Learn more about ADHD and find your community with these trusted resources.

The organizations and resources listed are not affiliated with nor are they controlled or influenced by Supernus Pharmaceuticals, Inc.

Attention Deficit Disorder Association (ADDA)

One of the largest communities dedicated exclusively to helping adults with ADHD live better lives.

Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD)

A nonprofit organization supporting more than 22 million American children and adults living with ADHD.

National Institutes of Mental Health (NIMH)

The federal agency transforming the understanding and treatment of mental illnesses, including ADHD.

ADDitude

A trusted resource for families and adults living with ADHD and related conditions, and for the professionals who work with them.

FAQs

Find answers to common questions about Qelbree and ADHD.

ADHD FAQs

Real ADHD stories

See the difference Qelbree is making in helping real people manage their ADHD.

Explore stories

Join Qelbree Insider

Get valuable information about Qelbree and managing ADHD.

INDICATION

Qelbree^® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE